Neuronal apoptosis is regulated by a complex series of molecular events, which in many cases culminate in activation of the conserved mitochondrial pathway of death characterized by the activation of the apoptosome. Numerous signals, which activate this conserved death pathway have been identified (for example, Ref. 1). Increasing evidence indicates that one such regulatory signal may involve activation of the c-Jun N-terminal kinases (JNKs) 1 (2) . JNKs, also known as stress-activated kinases (SAPK), are a family of three (JNK1, -2, -3) kinases, which are activated by numerous stimuli including cytokines, osmotic stress, and death inducing stimuli such as growth factor deprivation, DNA damage, dopaminergic toxins, axotomy, and ischemic insult (3) (4) (5) (6) (7) (8) (9) (10) (11) . The JNK family members are key regulators of the transcription factor c-Jun. JNK-mediated phosphorylation on Ser 63 and Ser 73 leads to transcriptional activation of c-Jun and the AP-1 complex (12) (13) (14) . The JNKs themselves are activated by upstream kinases of the mitogen-activated protein kinase family including MKK4 and 7, which are in turn activated by a larger group of upstream kinases including MEKKs, MLKs, and ASK1 (5, 15, 16) .
The biological role of the JNK/c-Jun pathway is varied and likely depends upon the biological context. c-Jun activation has a clear role in proliferation (17) and differentiation (18) . For example, c-Jun deficiency leads to cell cycle defects in fibroblasts and impaired hepatogenesis (17, 18) . Also, JNK1/2 double-deficient mice display neuronal tube developmental defects (19) . The role of the JNK/c-Jun pathway in cell death however, is controversial. A number of studies have attributed both proapoptotic and antiapoptotic functions for the JNKs (see Refs. 20 and 21 for review). In neuronal systems, a large and growing body of evidence suggests that the JNK/c-Jun pathway can function in a proapoptotic manner. JNK3 is predominately expressed in the brain and is most consistently associated with neuronal death. For example, JNK3 is critical for c-Jun phosphorylation and death induced by focal ischemia in vivo, while JNK1 and 2 deficiency do not appear to play a role (9) . JNK3 is also critical for c-Jun phosphorylation and dopaminergic loss in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease (11) . However, in this case, JNK2 also appears to mediate neuronal loss (11) . The crucial role for c-Jun as a downstream target of JNK-mediated neuronal death is supported by the observations that in cases where JNK deficiency inhibits death, c-Jun phosphorylation is also reduced. In these paradigms, c-Jun has been shown to be a required factor in death signaling. Examples of such linkages have been observed in neuronal death paradigms in vitro, e.g. NGF deprivation (10, (22) (23) (24) and DNA damage (6) ) and in vivo (e.g. ischemia (9) and models of Parkinson's disease (7, 8, 11) .
Whereas the canonical JNK-c-Jun pathway appears crucial in many instances of neuronal death, JNKs are also known to directly regulate other transcription factors and death regulators. These include the tumor suppressor p53 (25, 26) , ATF2 (27) , c-Myc (28), and Bcl-2 family members such as Bim (10, 29) . For example, in non-neuronal systems, p53 can be phosphorylated and stabilized by JNK phosphorylation (25, 26) . JNKs have also been shown to regulate BIM through direct phosphorylation as well as through induction of the AP-1 re-sponse (10, 24, 29) . Therefore, it is unclear whether JNKmediated neuronal death necessarily occurs through c-Jun or whether other death signals may also be of central importance. The significance of this question is also supported by observations that c-Jun activation can occur without concomitant neuronal death. This is most clear in cases of neuronal axotomy where prolonged c-Jun activation has been observed (30) and it has been suggested that c-Jun may in fact participate in regenerative processes (31, 32) .
In the present study, we examined the importance of the JNK/c-Jun pathway in the context of two neonatal models (sciatic and facial) of axotomy. Here we demonstrate that c-Jun activation is not necessarily the main component of JNK-mediated death. We show that while JNK3 deficiency inhibits c-Jun activation and protects peripheral sensory neurons from death, the protection afforded by JNK3 deficiency in facial motor neurons is not accompanied by reduced c-Jun phosphorylation. Accordingly, we suggest that, at least in certain neuronal contexts, JNK-mediated death signals act through other c-Jun-independent signals.
MATERIALS AND METHODS
Facial Nerve Axotomy-Axotomy of the right facial nerve was performed on postnatal day 1 mouse pups. Briefly, pups (C57/Bl background) were anesthetized with a gas mixture of 2-5% isofluorane and O 2 at a flow rate of 1 liter/min, a 1-cm incision (medial to lateral) was made caudal to the right ear. The musculature was separated to expose the facial nerve. The branches of the right facial nerve were transected as they exited the stylomastoid foramen. The musculature was closed and the skin was sutured together with Prolene 6 -0 suture (Johnson & Johnson) . Mice were sacrificed 24 h or 4 days following axotomy. For quantitation of survival, every fifth section through the facial nucleus was evaluated by cresyl violet staining and the total number of live motor neurons was evaluated both ispialteral and contralateral to the axotomy as previously described (33) .
Sciatic Nerve Axotomy-Neonatal pups from mice (JNK knockout and littermate controls; C57/Bl background see below) were utilized for these studies. Sciatic nerve axotomy was performed on postnatal day 1 pups as previously described (34) . Briefly, the animals were anesthetized by a gas mixture of 2-5% isofluorane and O 2 at a flow rate of 1 liter/min, an incision was made in the right leg parallel to the femur. The nerve was transected at mid-thigh level. The pups were returned to their mothers after suturing. At the indicated times, the animals were sacrificed by transcardial perfusion as described above. Right and left L4-L6 dorsal root ganglia (DRGs) with attached vertebra were dissected and fixed by immersion in Bouins fixative (34) . Tissue was then embedded in paraffin and 5-m serial sections were cut using a rotary microtome and stained with hematoxylin and eosin as previously described (35) . To obtain neuronal counts, neurons showing a nucleolus were counted in every fifth section of the L5 ganglion both ipsilateral and contralateral to the axotomy. Alternatively, spinal cord containing L4-L6 DRGs were removed after perfusion and postfixed in 4% PFA in 0.1 M phosphate buffer overnight at 4°C as previously described (36) . The tissue was cryoprotected in 10% sucrose solution in 0.1 M phosphate buffer as previously described (36). 14-m cryostat sections were obtained for immunofluorescent analyses (see below).
Knockout Mice-For knockout studies, JNK3 and JNK2 knockouts were obtained by heterozygous or heterozygous/homozygous knockout pairings. Newborn pups were axotomized as described above. Immediately prior to perfusion and fixation, tail clips were obtained for genotyping. JNK3 knockout embryos were genotyped using CCTGCTTCT-CAGAAACACCCTTC (MJ3B3), CGTAATCTTGTCCACAGAAATCCC-ATAC (MJ3F3) and CTCCAGACTGCCTTGGGAAAA (PGKP1) primers in one PCR reaction under following PCR conditions: 95°C, 5 min (1 cycle); 95°C, 1 min; 58°C, 1 min (Ϫ1.0°C/cycle); 72°C, 1 min (10 cycle); 95°C, 1 min; 48°C, 1 min; 72°C, 1 min (20 cycle); 72°C, 5min. JNK2 were genotyped under identical conditions. However GTTAGACAAT-CCCAGAGGTTGTGTG (MJ2F5), CCAGCTCATTCCTCCACTCATG (PGKT1), and GGAGCCCGATAGTATCGAGTTACC (MJ2B3) primers were utilized.
Immunofluorescence .4 containing 0.3% Triton X-100. After 3 washes with phosphatebuffered saline, sections were then incubated with CY3-conjugated secondary antibody (Jackson 1:200) for 3 h at room temperature. Sections were then incubated with Hoechst 33258 to visualize nuclei as previously described (37) . Quantitation of phosphorylated c-Jun or cJun positive neurons was assessed by counting the number of CY3-positive neurons in at least two separate midsections of each nuclei. To evaluate the intensity of staining, a random field for each nucleus was chosen. Densitometry was performed by subtracting background signal from each positive staining neuron in that field using a computer-based image analysis system (Northern Eclipse, Empix Imaging). For each nucleus, the densitometry values were averaged. This was performed for nuclei both ipsilateral and contralateral to the axotomy. Each data point is the representation of at least three different animals and is presented as mean Ϯ S.E.
RESULTS

JNK3 Modulates Death of Facial Motor
Neurons-Axotomy of the facial nerve in neonates results in death of neurons of the facial motor nuclei. Previous work has shown that this results in apoptotic death, which is associated with caspase induction (33, 38) . Utilizing this model, we first asked whether JNKs might be required for death. Because, JNK2 and -3 are most associated with death of neurons, we focused on these two JNK family members. Axotomy was performed on JNK3 knockout mice or littermate controls and the number of surviving neu- rons in the facial motor nucleus was examined 4 days following axotomy. As shown in Fig. 1B , axotomy resulted in survival of ϳ13% of facial motor neurons in littermate control mice 4 days following axotomy. In contrast, there was almost 3-fold the number of surviving neurons (37% survival) in JNK3-deficient mice under the same conditions (Fig. 1D) . JNK2-deficient nuclei were slightly more resistant to death than JNK3-deficient neurons (43% survival). Interestingly, while JNK2/3 doubledeficient mice showed the best protection (52% survival), the protection was not synergistic or even additive in nature. In the uninjured control nucleus, healthy neurons displayed centrally located nucleus and dark nissl staining of the cytoplasm. In contrast, dying neurons of control animals showed pyknotic nuclei and loss of Nissl staining. This was partially reversed in JNK3-, JNK2-, and JNK2/3-deficient animals (Fig. 1) . Taken together, these data indicate that both JNK3 and JNK2 play JNK3 Modulation of Motor Neuron Death Occurs Independently of c-Jun Phosphorylation-We next determined whether JNK2 or JNK3 deficiency mediated protection is accompanied by reduced c-Jun phosphorylation and activation as reported in other neuronal death paradigms (for example, Refs. 9 and 11)). We first examined c-Jun phosphorylation at Ser 63 using a phospho-Ser 63 -specific antibody. An increase in the number of Ser 63 c-Jun-positive neurons was detected 24 h following axotomy in the ipsilateral axotomized side when compared with non-axotomized contralateral nuclei in wild-type mice (Fig. 2) .
This increase was not apparent 4 days following axotomy as expected due to the death of axotomized facial neurons at this time (see Fig. 1 ). Interestingly, the basal level of phospho c-Jun positive neurons in the contralateral side was slightly elevated at 24 h in comparison to 4 days. This is likely due to indirect effects of the axotomy on the contralateral control nucleus.
Consistent with previous reports (9, 11), JNK2 deficiency mediated neuroprotection was accompanied by reduced number of phospho c-Jun-positive neurons (Fig. 2, A and B) . The number of phospho-c-Jun-positive neurons was elevated in JNK2-deficient mice at 4 days in comparison to wild-type mice as one would expect from an increased number of surviving neurons. It was also elevated in comparison to the contralateral side at 4 days, suggesting that Ser 63 c-Jun phosphorylation is sustained, albeit at lower levels than at 24 h. JNK2/3 doubledeficient mice showed further reduced Ser 63 c-Jun phosphorylation in comparison to JNK2 alone (Fig. 2, A and B) , reflecting the protection observed (Fig. 1) . In this case, the number of Ser 63 c-Jun-positive neurons was reduced down to levels observed on the contralateral side at 24 h, suggesting that a combination of JNK2 and -3 are important for the c-Jun phosphorylation increase observed following axotomy. Surprisingly, however, JNK3 deficiency alone failed to reduce the number of Ser 63 c-Jun-positive neurons at 24 h. There was no significant difference between JNK3-deficient and wild-type mice in Ser 63 phosphorylation at 24 h. This finding contrasts to that of JNK2 or JNK2/3 double-deficient neurons.
While the above observations indicated that JNK3 deficiency alone did not affect the total number of Ser 63 -positive neurons, we examined whether JNK3 deficiency might affect the overall intensity (per neuron) of c-Jun phosphorylation. To examine this, we performed densitometric analyses of Ser 63 -positive neurons in the different animal groups (Fig. 2C) . In wild-type animals, the average intensity of Ser 63 staining was elevated following axotomy at 24 h. While this intensity was reduced in JNK2-or JNK2/3-deficient nuclei following axotomy at 24 h, JNK3-deficient nuclei showed no such reduction. Similarly, total Ser 63 phosphorylation activity, as defined by the number of positive neurons multiplied by average intensity of each neuron, was also not affected in JNK3-deficient facial nuclei (Fig. 2D ) when compared with wild-type mice (24 h). In contrast, JNK2 or JNK2/3 deficiency significantly reduced total Ser 63 c-Jun phosphorylation activity. At 4 days, the intensity of Ser 63 staining was still sustained when compared with the contralateral side. However, there was no difference between any of the groups.
c-Jun, depending upon the context, may be differentially phosphorylated at the two major phosphorylation sites of cJun. For example, following medial forebrain axotomy in the adult rat, Ser 73 phosphorylation and not Ser 63 phosphorylation is observed (7) . Accordingly, we also evaluated phosphorylation of c-Jun at Ser 73 . Similar to that observed with Ser 63 phosphoepitope-specific antibody, we observed an increase in levels of Ser 73 c-Jun phosphorylation in axotomized control mice, which did not differ from that observed with JNK3-knockout mice (Fig. 3) . Like with Ser 63 , Ser 73 phosphorylation was negatively impacted by JNK2 or JNK2/3 deficiency.
Finally, we determined whether c-Jun levels by itself may be regulated by JNK deficiency. As shown in Fig. 4 , there were relatively high basal levels of c-Jun in the contralateral nuclei at both 24 and 4 days and a modest increase in numbers (148 ipsi versus 104 contra) and intensity (109 ipsi versus 74 contra) of c-Jun at 24 h. Similar to that observed with Ser 63 or Ser 73 c-Jun phosphorylation, this increase was not affected by JNK3 deficiency while JNK2 or JNK2/3 double-deficient mice showed reduced c-Jun levels. Taken together, these data indicate that JNK3-mediated protection is not correlated with a reduction in c-Jun activation. Most importantly, these data indicate that c-Jun activation per se is not the only JNK-mediated signal required for facial axotomy-induced death. Because protection afforded by JNK3 deficiency was not accompanied by reduced c-Jun phosphorylation following facial axotomy, we asked whether other potential JNK targets may be modulated and required for neuronal death. We examined additional select transcription factors, ATF2 and Elk1, which are also regulated by the JNKs (39, 40) . However, we could not detect any increased phosphorylation or induction of these factors following axotomy 24 h following axotomy when c-Jun activation was pronounced (data not shown). Evaluations of potential induction in these cases were performed by immunofluorescent analyses utilizing ATF2 and ELK1 antibodies or phosphospecific antibodies recognizing activated ATF2 and Elk1. In fact, the phospho-ATF2 and phospho-Elk1 signals decreased 24 h following axotomy on the ipsilateral side consistent with what has previously been reported in other neuronal stress situations (40) . p53 has also been previously shown to be important for neuronal death under many circumstances (for example, Refs. [41] [42] [43] . In addition, several reports have indicated that p53 stability and transactivational capacity is directly modulated by JNKs (25, 26) . Accordingly, we asked whether p53 induction could be observed following facial axotomy. However, we could not detect any p53 induction following facial axotomy by immunofluorescent analyses while we could detect such as change in mice exposed to stroke as positive control (data not shown). Similarly, previous reports have also suggested that the prodeath BCl2 family member Bim is a direct target of JNKs and that JNK-mediated phosphorylation potentiates its death-promoting effects (10, 24, 29) . Accordingly, we next examined whether Bim is phosphorylated on the described JNK-mediated site (Ser 65 ) and whether this phosphorylation is reduced in JNK3-deficient mice following axotomy. However, we could not detect increased Bim phosphorylation by immunofluorescence or Western blot analyses 24 h following axotomy (data not shown). In addition, no difference in Bim phosphorylation in JNK3-deficient facial nuclei was observed when compared with control mice (data not shown). These results suggest that protection mediated by JNK3 deficiency is not due to induction of ATF2/Elk1 or modulation of p53 or Bim signals.
JNK3 Is Required for c-Jun Phosphorylation and Death of DRG Neurons following Sciatic
Nerve Axotomy-The above observations were surprising to us, and we asked whether the lack of correlation between the protective effects of JNK3 deficiency and c-Jun phosphorylation might be universal to transection-mediated injuries, particularly in the neonate. Therefore, we also examined the role of JNK3 in DRG loss induced by sciatic nerve axotomy. As shown in Fig. 5 , JNK3 deficiency also protected DRGs from neuronal loss following axotomy. As previously reported in this paradigm, axotomy of the sciatic nerve in the neonate leads to ϳ25-40% death 7 days following axotomy (34) . We observed that JNK3 deficiency completely abolished this neuronal loss. c-Jun phosphorylation and activation is observed in the DRGs following sciatic axotomy in wild-type animals. In this paradigm, and in contrast to facial nerve axotomy, JNK3 deficiency on its own inhibited c-Jun phosphorylation at Ser 73 (Fig. 6 ), Ser 63 (Fig. 7) , and c-Jun induction (Fig. 8) . In this case, JNK2 deficiency had no effect on the induction of c-Jun phosphorylation (data not shown), highlighting another difference in JNK effects in DRGs when compared with the facial motor neurons. This result indicates that the discrepancy between JNK-mediated death pathways and c-Jun induction observed with facial axotomy cannot be generalized to all neonatal models of axotomy.
DISCUSSION
In paradigms of neuronal death involving activation and requirement of the JNKs, the general observation has been that c-Jun is concomitantly phosphorylated and required for death. Examples of this include the first reports demonstrating the importance of c-Jun in neuronal death in sympathetic neurons induced by NGF deprivation (22, 23) . Later studies have demonstrated the importance of JNK in mediating both c-Jun activation and death in this model (10, 24, 44) . Other examples of the importance of the c-Jun/JNK pathway in vitro include models of ␤-amyloid toxicity (45) and K ϩ deprivation (46, 47) , DNA damage (6), and arsenite-induced toxicity (48) . These links have also been made in in vivo models of neurodegeneration such as with the medial forebrain bundle axotomy and MPTP models of Parkinson's disease (7, 8, 11, 49) and in ischemic or excitotoxic injury (9, 50) . These observations suggest that c-Jun may be the most functionally relevant downstream death target of JNKs in neuronal death.
Our present results, however, indicate that this canonical signaling unit is not necessarily the only critical JNK-mediated death pathway. This observation is significant for several reasons. First, it shows that protection afforded by JNK3 deficiency is not always correlated with reduced c-Jun activation and is strongly suggestive that c-Jun does not necessarily have to be the major death-mediating target of the JNKs. It also indicates that while c-Jun may be phosphorylated during neuronal death, this phosphorylation does not necessarily lead to death. Several alternative JNK targets have been reported and they form at least two classes. The first involves members of the Bcl-2 family including Bim. Several reports have suggested that Bim is directly phosphosphorylated by JNK and lead to BIM death promoting activity through cell localization independent (10) or dependent processes (29) . Coincidentally, Bim levels also appear to be regulated by c-Jun (24, 52) during NGF deprivation. This suggests a dual mode of regulation by JNKs, one that is dependent upon c-Jun transactivation and one that is independent. The relative contributions of these two processes in NGF deprivation-induced death is unclear. The second class of alternative JNK targets include a variety of transcription factors other than c-Jun. Of relevance to the present work, JNKs have been shown to directly bind and phosphorylate p53, modulating its stability and transactivational capability (25, 26) . The potential relevance of these findings to neuro- nal death is intriguing. However, the relevance of any potential endogenous JNK-p53 pathway in neuronal death is unknown. At least in the facial axotomy model in the neonate, it does not appear that Bim or p53 are major players in axotomy-induced death. It is possible that other alternative JNK-associated transcriptional targets such as ATF2 and c-Myc activity may also participate in axotomy-induced loss.
Our results show a role for both JNK3 and JNK2 in facial axotomy induced death signal. This is consistent with recent reports showing that both JNK isoforms appears to participate in MPTP-induced death (11) . Our own results in vitro following DNA damage have also suggested that inhibition of multiple JNK isoforms is required for a protective response (6) . However, this is not always the case. In models of ischemia, JNK3 deficiency appears protective while JNK2 had no effect (9) . These observations indicate that the relative importance of any JNK isoform in neuronal death depends upon the context of the particular paradigm.
This context dependence also extends to the phosphorylation/induction of c-Jun. Our present results indicate that while c-Jun phosphorylation is completely dependent upon JNK3 and not JNK2 following sciatic nerve axotomy, other JNK members are likely important in c-Jun phosphorylation following facial axotomy including JNK2. However, we cannot rule out the possible importance of other non-JNK related signals. Interestingly, a recent report indicated that c-Jun activation/induction is suppressed by JNK2 in fibroblasts (53) . The reason for the difference in this observation when compared with our own in facial motor neurons is unclear. Neurons contain additional JNK isoforms, which may lead to different responses than that observed in fibroblasts. Importantly, JNK2 has been shown to be able to activate c-Jun upon transient expression even in nonneuronal systems (53) . Our results as well as those showing a reduction of c-Jun activation in JNK2 knockouts following MPTP (11) suggest that in neurons, JNK2 can, but does not always, participate in c-Jun activation following a stress insult.
Currently, the reason for the differential c-Jun/JNK linkages in different systems is unknown. However, multiple scaffolding proteins have been identified which presumably mediate different signaling complexes (54) . These disparate complexes may regulate distinct biological signals. In support of this, differential cellular localization and induction of various JNK and JNKK isoforms have been described (55) . Therefore, it may be possible that different neuronal populations contain and activate distinct JNK-mediated signaling complexes.
It is important to emphasize that in some instances of neuronal injury, sustained c-Jun induction/activation does not necessarily lead to death (30, 32) . Our own data suggest that JNK3 deficiency mediated protection is not associated with reduced c-Jun activation. Recent evidence also indicates that the biological role of c-Jun in death may be dependent upon the existence and activation of other signaling pathways. For example, with tumor necrosis factor exposure, the JNK signal mediates death only in the absence of NFB (20) . In addition, it has also been suggested that different c-Jun containing transcriptional complexes give rise to distinct functional properties. For example, ATF2 is thought to redirect c-Jun activity toward CRE (instead of AP-1)-mediated sites (56) . The reason why c-Jun induction is not necessarily associated with death following facial axotomy is unclear.
In conclusion, while there is strong evidence for the importance of the c-Jun/JNK pathway in many instances of neuronal death, c-Jun is not necessarily the only downstream target of the JNK-mediated death pathway. Instead, it is likely that JNK3 may mediate other death pathways independent of c-Jun.
